Studies of Kidney Transplant Outcome

May 14, 2019 updated by: University of Minnesota
The purpose of this study is to improve outcome for kidney transplant recipients. There has not been commensurate improvement in medium and long-term outcomes. Ongoing clinical research is necessary to improve transplant outcomes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study is looking at information already collected of transplant outcomes (short, medium and long-term complications and quality of life). This will specifically look at:

  1. 10 year follow-up of steroid-free maintenance immunosuppression
  2. A cross-sectional study of infection after kidney transplantation (with emphasis on infection in steroid-free recipients
  3. An evaluation of the Delayed Graft Function (DGF) nomogram in Thymoglobulin treated recipients at the University of Minnesota

Study Type

Observational

Enrollment (Actual)

7500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Minnesota
      • Minneapolis, Minnesota, United States, 55414
        • University of Minnesota

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Kidney transplant recipients at the University of Minnesota

Description

Inclusion Criteria:

  • Kidney Transplant Recipient at the University of Minnesota
  • Kidney Transplant Recipients on steroid-free maintenance immunosuppression

Exclusion Criteria:

  • Non-kidney transplant patients at the University of Minnesota

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Kidney Transplant Recipients
Kidney Transplant Recipients at the University of Minnesota since 1984. The study looks at a 10 year followup of steroid-free maintenance immunosuppression, post-transplant infections and evaluation of the DGF nomogram in Thymoglobulin on patients at the University of Minnesota.
Drug: Steroid-Free Maintenance Immunosuppression
10 year follow-up of steroid-free maintenance immunosuppression
Other Names:
  • Immunosuppression
  • Steroid-Free
Other: Infection After Kidney Transplantation
A cross-sectional study of infection after kidney transplantation (with emphasis on infection in steroid-free recipients).
Other Names:
  • Infection
  • Transplantation
  • Steroid-Free
Drug: Evaluation of the DGF nomogram in Thymoglobulin
An evaluation of the DGF nomogram in Thymoglobulin treated recipients at the University of Minnesota
Other Names:
  • Thymoglobulin

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Data Analysis
Time Frame: 10 year followup
All studies are analyses from the Transplant Outcomes Database. Recipients have signed consent to have medical information entered into the database for these analyses. The database contains information on short, medium and long-term results.
10 year followup

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Minnesota

Collaborators

Genentech, Inc.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2009

Primary Completion (Actual)

May 6, 2019

Study Completion (Actual)

May 6, 2019

Study Registration Dates

First Submitted

August 19, 2010

First Submitted That Met QC Criteria

January 13, 2011

First Posted (Estimate)

January 17, 2011

Study Record Updates

Last Update Posted (Actual)

May 15, 2019

Last Update Submitted That Met QC Criteria

May 14, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 00011652

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-Transplant Infections

Clinical Trials on Steroid-Free Maintenance Immunosuppression

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe